Dr. Pimpawan Boapimp, MD

Dr. Boapimp practices at Wmed Health in Kalamazoo, Michigan.

Dr. Boapimp's NPI, 1548371586, was assigned on August 31, 2006. Dr. Boapimp holds Michigan license 4301099705.

Dr. Boapimp's primary practice is Wmed Health, at 1000 Oakland Dr, Kalamazoo, MI 49008-1282. The practice phone is (269) 337-4347.

Dr. Boapimp's primary practice is Wmed Health in Kalamazoo, Michigan. Dr. Boapimp is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Boapimp to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boapimp practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Boapimp's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Boapimp's licenses on file in 2 states: Michigan and Nebraska.

CMS data shows 62 Medicare services from Dr. Boapimp across 2 procedure codes in 2024, for 58 Medicare patients. Medicare paid $4,345 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 58 Medicare patients who saw Dr. Boapimp in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boapimp's median patient age at 66, with 45% women.

In 2024, Dr. Boapimp wrote 699 Medicare Part D claims for 101 patients. 50% of them were for generic drugs. CMS names the drug for 524 of them, across 18 drugs with 11 or more claims each, at $1,258,403 in total drug cost. In 2023, CMS named 1,058 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Boapimp for performance year 2024, reported as part of a group. Dr. Boapimp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boapimp as offering telehealth.

CMS Open Payments shows 15 general payments to Dr. Boapimp from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Gilead Sciences, Inc. paid the most, $405.